CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

GlobeNewswire Pharma
Original article

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Neutral
AI Analysis

Summary

Syndax Pharmaceuticals granted inducement stock options to purchase 250,700 shares to eight new employees on July 1, 2026, with standard four-year vesting schedule under its 2023 Inducement Plan.

Importance:2/10
Sentiment:
0.00
inducement grantsequity compensationemployee retentionstock options
Related Companies

Read the original article

Published by GlobeNewswire Pharma on July 1, 2026 8:01 PM

Read Original